<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
<channel>
<title>IDAHO TECHNOLOGY INC. - PRWeb Press Release Account Feed</title>
<link>http://www.rsspad.com/rss2a/123639.xml</link>
<description>IDAHO TECHNOLOGY INC. - Press Releases</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
     <title>Idaho Technology, Inc. Plague and Tularemia Detection Kits Receive FDA Clearance</title>
     <link>http://www.prweb.com/releases/2008/01/prweb601062.htm</link><description>   <![CDATA[ <P>Idaho Technology, Inc. (ITI), a molecular biology instrumentation and reagents business in Salt Lake City, Utah, is proud to announce clearance from the Food and Drug Administration (FDA) for marketing of two new biothreat detection kits, the JBAIDS Plague and JBAIDS Tularemia Detection Kits. Both kits utilize real-time PCR technology to identify the causative agents of plague (Yersinia pestis) and tularemia (Francisella tularensis). (PRWeb Jan 5, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2008/01/prweb601062.htm">http://www.prweb.com/releases/2008/01/prweb601062.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2008/01/prweb601062.htm</guid>
        </item>
<item>
     <title>Idaho Technology Awarded Grant for Pathogen Detection System</title>
     <link>http://www.prweb.com/releases/2007/05/prweb527097.htm</link><description>   <![CDATA[ <P>Idaho Technology Inc. announced today that the company has been awarded a grant from the National Institutes of Health and National Institute for Allergy and Infectious Disease Cooperative Research Partnerships for influenza product development.  The grant will aid in funding a novel diagnostic platform for identifying a panel of specific respiratory viruses including H5N1 avian influenza. This platform will enhance surveillance and diagnosis of pandemic influenza strains while also diagnosing common respiratory viruses seen during yearly respiratory virus epidemic cycles. (PRWeb May 18, 2007)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2007/05/prweb527097.htm">http://www.prweb.com/releases/2007/05/prweb527097.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2007/05/prweb527097.htm</guid>
        </item>
<item>
     <title>Idaho Technology Inc. Receives Exclusive Licensing for &#039;Monitoring Amplification with FRET Probes&#039; Patent from University of Utah</title>
     <link>http://www.prweb.com/releases/2007/01/prweb497885.htm</link><description>   <![CDATA[ <P>Idaho Technology Inc. announced today that the company has received exclusive licensing rights to U.S. Patent No. 7,160,998, entitled &quot;Monitoring Amplification With FRET Probes,&quot; issued to the University of Utah Research Foundation on January 9, 2007. (PRWeb Jan 18, 2007)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2007/01/prweb497885.htm">http://www.prweb.com/releases/2007/01/prweb497885.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2007/01/prweb497885.htm</guid>
        </item>
<item>
     <title>Idaho Technology Inc. is Awarded U.S. Patent for a High-Speed Thermal Cycler</title>
     <link>http://www.prweb.com/releases/2006/09/prweb434512.htm</link><description>   <![CDATA[ <P>The U.S. Patent and Trademark Office issued the University of Utah a patent for a high-speed thermal cycler. This patent reinforces the University&#039;s patent portfolio in the area of real-time nucleic acid amplification, quantification, and melting analysis. The patents in this unique portfolio are exclusively licensed to Idaho Technology Inc., a molecular biology instrumentation and reagents business in Salt Lake City, Utah. (PRWeb Sep 9, 2006)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2006/09/prweb434512.htm">http://www.prweb.com/releases/2006/09/prweb434512.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2006/09/prweb434512.htm</guid>
        </item>
<item>
     <title>Idaho Technology Offers Analyte Specific Reagent (ASR) Products</title>
     <link>http://www.prweb.com/releases/2005/01/prweb193832.htm</link><description>   <![CDATA[ <P>Idaho Technology, Inc. today announced that it is now registered with the U.S. Food and Drug Administration (FDA) to develop, manufacture, and sell Analyte Specific Reagent (ASR) products for molecular diagnostics. (PRWeb Jan 5, 2005)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2005/01/prweb193832.htm">http://www.prweb.com/releases/2005/01/prweb193832.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2005/01/prweb193832.htm</guid>
        </item>
<item>
     <title>Idaho Technology and Roche Sign PCR License Agreement</title>
     <link>http://www.prweb.com/releases/2005/01/prweb193805.htm</link><description>   <![CDATA[ <P>Idaho Technology, Inc. and Roche have signed a license  agreement granting Idaho Technology non-exclusive, worldwide access to Roche's PCR (polymerase chain  reaction) patents. (PRWeb Jan 5, 2005)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2005/01/prweb193805.htm">http://www.prweb.com/releases/2005/01/prweb193805.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2005/01/prweb193805.htm</guid>
        </item>
</channel>
</rss>